Neurocrine Biosciences
NBIX
#1654
Rank
C$18.17 B
Marketcap
C$181.10
Share price
1.48%
Change (1 day)
7.43%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024: C$0.83 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are C$2.68 Billion. In 2024 the company made an earning of C$0.83 Billion, an increase over its 2023 earnings that were of C$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024C$0.83 B96.41%
2023C$0.42 B41.13%
2022C$0.30 B73.74%
2021C$0.17 B-8.82%
2020C$0.19 B77.78%
2019C$0.10 B49.83%
2018C$71.53 M-142.57%
2017-C$0.17 Billion-14.73%
2016-C$0.2 Billion53.15%
2015-C$0.13 Billion46.25%
2014-C$87.99 Million29.66%
2013-C$67.86 Million-3530.8%
2012C$1.97 M-95.73%
2011C$46.33 M
2009-C$65.14 Million-45.38%
2008-C$0.12 Billion-58.87%
2007-C$0.29 Billion87.3%
2006-C$0.16 Billion351.97%
2005-C$34.25 Million-52.09%
2004-C$71.49 Million-10.98%
2003-C$80.31 Million
2001-C$59.95 Million
1999-C$27.04 Million108.32%
1998-C$12.98 Million
1996C$3.96 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.18 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.26 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.73 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$35.7 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.05 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$69.05 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$6.56 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
C$2.16 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK